UF researchers develop new CRISPR-based tool for cancer diagnosis
UF researchers developed a new CRISPR-powered method for noninvasive blood tests that could help clinicians diagnose cancer at earlier stages.
All Posts by
UF researchers developed a new CRISPR-powered method for noninvasive blood tests that could help clinicians diagnose cancer at earlier stages.
The UF Health Cancer Center hosted the 15 AACR Global Scholar-in-Training Awardees on April 19-20.
The team will assess whether a new therapeutic can intercept cellular processes before pancreatic cancer develops.
The discovery could have implications for cancer, the aging process, and growth and development.
Rachel Newsome won for her research targeting the gut microbiome in lung cancer patients to improve their immune response.
The Rising Star Award recognizes exceptional early-career clinical faculty whose actions and activities consistently exemplify clinical excellence.
Two oncologists were honored for their work on clinical trials for adolescent and young adult patients with cancer.
The study found Black and Hispanic people had higher rates of initiation and Black people had higher rates of subsequent use.
Mansi Dalal, M.D., is one of the Cancer Center's clinical investigators who has dedicated her career to developing better cancer treatments.
In an interview with OncLive, Burak Zeybek, M.D., discusses the phase 1 NOW trial investigating neoadjuvant olaparib in patients with ovarian cancer.